Trial intelligence / Profile preview

AoA Guided Thoracic Epidural Analgesia for Abdominal Aortic Repair

NCT06609993Completed

Start
Dec 2017
Primary completion
Mar 2020
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection and bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms). Primary endpoint: Pain perception intraoperatively. Started Dec 2017; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injectionbupivacaine hydrochloride 0.75% injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06609993.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06609993.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call